Nam, Sara L.
Abril, Arantza
McKay, Gillian
Casey, Sara E.
Bossard, Claire
Moore, Ann M.
Seyoum, Tewodros
Christou, Aliki
Paracchini, Stefania
Lledó Weber, Patricia
Fetters, Tam
Singh, Neha
Grau, Enric
Sleiman, Tatayana
Blanchet, Karl
Funding for this research was provided by:
Elrha (Purchase Order No. 200014730)
Article History
Received: 27 August 2025
Accepted: 13 November 2025
First Online: 7 December 2025
Declarations
:
: Ethical approval for the global prioritisation survey was granted by the University of Geneva Ethics Committee (Ref: CUREG-20250213-265-2). All participants in the survey provided informed consent electronically before beginning the questionnaire. For the regional consultations, participants provided verbal consent at the start of each session after being informed of the objectives, procedures, and use of anonymised outputs. Participation was voluntary, and no identifiable personal information was collected.
: Not applicable. This study did not involve individual patient data, identifiable personal information, or images. All survey and consultation data were anonymised and aggregated. The participants provided informed consent to participate in the survey and consultations.
: Karl Blanchet, a member of the study team who provided overarching strategic input, serves as Co-Editor in Chief of BMJ Global Health. Neha Singh is an Associate Editor, and at the time of submitting a revised manuscript, Sara Nam was being on-boarded as a Associator Editor. Non of the above were involved in the editorial or peer review process for this manuscript. The authors declare no other competing interests.